Terminated PHASE4 INTERVENTIONAL 2-arm NCT01778647

Omega-3 Fatty Acids as an Adjunctive Therapy for Stimulants in Children With ADHD

Sponsor: Antonios Likourezos

Conditions Attention Deficit Hyperactivity Disorder

Interventions Stimulants plus Lovaza Stimulants plus placebo

Updated 8 times since 2017 Last updated: Dec 8, 2023 Started: Dec 31, 2009 Primary completion: Jul 31, 2010 Completion: Jul 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Co-Investigators left the Institution.

Other terminated trials from Antonios Likourezos

See all terminations from Antonios Likourezos

Other Attention Deficit Hyperactivity Disorder trials with similar outcome

Browse all Attention Deficit Hyperactivity Disorder trials

A PHASE4 clinical study on Attention Deficit Hyperactivity Disorder, this trial is terminated or withdrawn. The trial is conducted by Antonios Likourezos and has accumulated 8 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2024 — Jul 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jan 2024 [monthly]

Terminated PHASE4
Sep 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 3 earlier versions

Jun 2018 — Sep 2018 [monthly]

Terminated PHASE4
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Antonios Likourezos

Data source: Maimonides Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brooklyn, United States